Bone Biologics BBLG
NASDAQ BBLG
$0.42 -0.01 (-2.33%)
As of: Oct 21, 2026 · 3:59 PM EDT

Bone Biologics (BBLG) Operating Margin (2023 - 2024)

Updated

Bone Biologics' Operating Margin was -1.91% in FY2016.

Analysis

Bone Biologics (BBLG) Operating Margin (2023 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 13.44%
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 33.60%
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 18.08%
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn 25.18%
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 21.65%
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 13.31%
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 29.48%
10 Bone Biologics 738,825.63 -21.32 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -354,327.84%
Dec 31, 2023 -332,380.52%
Sep 30, 2023 -388,225.75%
Jun 30, 2023 -710,249.53%
Mar 31, 2023 -566,103.78%
API Access

Bone Biologics Operating Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-margin&ticker=BBLG&period=max&api_key=YOUR_API_KEY